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Summary
Growth factor binding to EGFR drives conformational changes that promote homodimerization 
and transphosphorylation, followed by adaptor recruitment, oligomerization, and signaling through 
Ras. Whether specific receptor conformations and oligomerization states are necessary for 
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efficient activation of Ras is unclear. We therefore evaluated the sufficiency of a phosphorylated 
EGFR dimer to activate Ras without growth factor by developing a chemical-genetic strategy to 
crosslink and “trap” full-length EGFR homodimers on cells. Trapped dimers become 
phosphorylated and recruit adaptor proteins at stoichiometry equivalent to that of EGF-stimulated 
receptors. Surprisingly, these phosphorylated dimers do not activate Ras, Erk, or Akt. In the 
absence of EGF, phosphorylated dimers do not further oligomerize or reorganize on cell 
membranes. These results suggest that a phosphorylated EGFR dimer loaded with core signaling 
adapters is not sufficient to activate Ras and that EGFR ligands contribute to conformational 
changes or receptor dynamics necessary for oligomerization and efficient signal propagation 
through the SOS-Ras-MAPK pathway.
Graphical abstract
Liang et al. demonstrate that the recruitment of key signaling adapters to stable phosphorylated 
EGFR dimers is not sufficient for the activation of Ras and its downstream pathways. Binding of 
EGFR ligands induces conformational changes and receptor dynamics necessary for 
oligomerization and efficient signal propagation through the SOS-Ras-MAPK pathway.
Introduction
Epidermal growth factor receptor (EGFR) is a broadly expressed receptor tyrosine kinase 
frequently mutated or overexpressed in cancer. The steps of EGFR activation by ligands 
such as EGF have been extensively studied. Biochemical, imaging, and structural evidence 
support a model wherein monomers of EGFR are inactive and in equilibrium with a 
population of inactive dimers (Chung et al., 2010; Jura et al., 2009). Binding of EGF 
stabilizes receptor conformations that expose an extracellular dimerization interface, 
triggering accumulation of active EGFR dimers (Ferguson et al., 2003; Ogiso et al., 2002). 
One intracellular kinase then allosterically activates the other, resulting in phosphorylation 
of C-terminal tyrosines (Zhang et al., 2006) (Figure 1A). Phosphorylated tyrosines recruit 
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signaling adapters such as Shc, Grb2, and SOS, which stimulate a variety of downstream 
pathways (Margolis et al., 1989). Among these, the Ras-MAPK (mitogen-activated protein 
kinase) pathway is a particularly important regulator of cell behaviors such as proliferation 
and migration.
The formation of phosphorylated EGFR dimers is generally considered sufficient to initiate 
Ras signaling because the dimers recruit the Ras-GEF (guanine nucleotide exchange factor) 
SOS to the membrane, and membrane-localized SOS is sufficient to activate Ras under a 
variety of conditions (Aronheim et al., 1994; Christensen et al., 2016; Toettcher et al., 2013). 
However, conflicting observations raise questions regarding whether a phosphorylated dimer 
is a competent signaling unit, sufficient to activate Ras, in the absence of EGF. For example, 
dimerization of a chimeric receptor's intracellular domains with rapamycin derivatives was 
sufficient to induce EGFR phosphorylation and downstream Erk phosphorylation 
(Muthuswamy et al., 1999). In contrast, dimerization of EGFR on cancer cell lines with 
therapeutic antibodies resulted in phosphorylated EGFR but no Erk phosphorylation 
(Yoshida et al., 2008). While these examples varied greatly in experimental design—for 
instance, the antibodies specifically targeted EGFR's extracellular domain and locked EGFR 
dimers in an inactive conformation (Li et al., 2005), whereas the chimeric EGFR had its 
extracellular domain replaced with the transmembrane and extracellular domain of p75 
Neurotrophin receptor—it remains difficult to rationalize how the phosphorylated 
intracellular domains could be signaling competent in one study but not in another.
A possible resolution of this conundrum is the requirement for a specific tertiary or 
quaternary structure beyond the dimer, promoted by EGF binding, to efficiently activate Ras. 
Upon EGF binding, dimers undergo rapid spatial rearrangement into oligomers and 
nanoscale clusters (Figure 1B) (Ariotti et al., 2010; Clayton et al., 2008; Ichinose et al., 
2004; Saffarian et al., 2007; van Lengerich et al., 2017), and these oligomers may promote 
downstream signaling (Huang et al., 2016; Kozer et al., 2013; Needham et al., 2016). 
However, because oligomerization and signaling changes occur on a similar timescale, it 
remains unclear whether specific spatial intermediates are a cause or consequence of 
downstream signaling.
We sought to determine whether a phosphorylated EGFR dimer is sufficient to activate Ras 
signaling without EGF. This question is challenging to answer, because receptor 
overexpression (Avraham and Yarden, 2011;Pedersen et al., 2005), mutations and 
truncations (Arkhipov et al., 2013; Bessman et al., 2014), and antibodies (Li et al., 2005; 
Schmiedel et al., 2008) can perturb the conformations adopted by EGFR and have 
unpredictable consequences on signaling. We addressed these challenges by developing a 
chemical genetic strategy based on targeted chemical crosslinking that allows for the 
preparation of a clean population of full-length receptor dimers, expressed at near-WT 
(wildtype) levels, and dimerized using long and flexible crosslinkers that do not significantly 
restrict receptor conformations. This strategy effectively decouples EGFR dimerization from 
other EGF-induced conformation changes and dynamics, allowing us to conclude that the 
critical function of EGF in Ras signal transduction is not limited to promoting the formation 
of a phosphorylated EGFR dimer, but also promoting receptor dynamics, conformations, or 
oligomeric states necessary for downstream signaling.
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Results
A Chemical Genetic System for Preparing Full-Length EGFR Dimers without Ligand
To decouple EGF-induced receptor dimerization from other EGF-induced conformation 
changes, we sought to exploit the equilibrium between monomers and inactive dimers on 
resting cells. We hypothesized that selectively reducing the off rate of EGFR dimers would 
stimulate autophosphorylation rates sufficient to overcome high endogenous levels of 
background phosphatase activity (Kleiman et al., 2011), thereby generating phosphorylated 
receptor dimers. First, we modified the N terminus of full-length EGFR with a flexible 
linker and a SNAP-tag, which rapidly forms a covalent bond with benzyl guanine (BG), as 
the chemical dimerization domain. When this construct was stably expressed in HEK293 
cells at physiological levels, we found that it was efficiently activated by the addition of 
nanomolar concentrations of EGF (Figure 1D). For the chemical dimerizer, we incorporated 
BG at the 5′-hydroxyl of double-stranded DNA molecules (DNA-BG)2, (20-mer; 
approximate length, 6.8 nm; Figure 1C). Addition of (DNA-BG)2 to live cells for 5 or 30 
min resulted in a higher molecular weight band by western blot, consistent with a trapped 
dimeric species (Figures 1D and S1). Blotting for phosphorylation of tyrosine 1068 
confirmed that the kinase domains of trapped dimers were active. Strikingly, we also 
observed pronounced differences in phosphorylated Erk between EGF-stimulated and 
trapped dimer receptors (Figure 1D). Consistently, and in multiple cell lines, we observed 
strong Erk and Akt signaling from EGF-stimulated SNAP-EGFR, and no signaling above 
background in the presence of (DNA-BG)2 (Figure S1). These results suggest that selective 
stabilization of an EGFR dimer is sufficient to stimulate kinase activity independent of 
additional conformational changes associated with EGF binding. However, receptor 
phosphorylation alone did not generate Ras-MAPK signaling.
Trapped EGFR Dimers Are Phosphorylated to a Similar Extent as EGF-Activated EGFR
Differences in EGFR phosphorylation levels between (DNA-BG)2 and EGF stimuli, as well 
as the pattern of phosphorylation (Ronan et al., 2016), could explain differences in 
downstream Erk activation. This hypothesis could be tested by quantitative western blotting, 
but quantitative comparison can be challenging between monomeric and crosslinked species, 
because large differences in molecular weight impact the transfer efficiency of proteins 
(Towbin et al., 1979). We therefore selectively melted (DNA-BG)2 crosslinks by boiling 
samples after cell lysis but prior to SDS-PAGE (Figure 2A).
Using the concentration of EGF and (DNA-BG)2 in Figure 1D, which gave EGFR 
phosphorylation in both conditions but Erk phosphorylation only with EGF, we used 
quantitative western blotting to compare the phosphorylation levels of a suite of tyrosines: 
Y1045, Y1068, Y1086, and Y1173. Notably, we observed phosphorylation to a similar 
extent for both conditions (Figures 2B and 2C) at a time point and EGF concentration 
sufficient for propagation of downstream signals. Increasing the concentration of (DNA-
BG)2 gives a similar result, illustrating the crosslinker was working near saturating 
conditions (Figure S2).
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Phosphorylated EGFR Dimers Are Not Sufficient to Stimulate Ras Activation
Mechanistically, several steps occur between the formation of a phosphorylated EGFR dimer 
and Erk activation. We therefore sought to identify the specific step at which the signaling 
capacity of EGF- and (DNA-BG)2-stimulated dimers diverged. Because Erk activation 
requires Ras-GTP formation, we first investigated whether signaling breakdown occurred at 
or before the level of Ras activation. To evaluate the activation status of Ras, we used the 
Ras-binding domain of Raf, which selectively binds Ras-GTP, to pull down GTP-bound 
activated Ras from wholecell lysates. We used the same concentrations of EGF and (DNA-
BG)2 as in our earlier assays and confirmed that, while EGF and (DNA-BG)2 stimulated 
similar levels of Y1068 phosphorylation after 5 min, only EGF-activated EGFR was capable 
of activating Erk signaling. Analyzing the same lysates for Ras activation, we observed 
efficient pulldown of Ras-GTP in EGF-treated cells, while little to no Ras-GTP was detected 
in cells treated with (DNA-BG)2 (Figures 3A and 3B). This was particularly surprising, 
given that Y1068 is widely considered the primary site responsible for recruiting the 
Grb2/Sos complex that activates Ras (Yamauchi et al., 1997). Thus, phosphorylated EGFR 
dimers are not sufficient to activate Ras.
Trapped EGFR Dimers Recruit Key Adaptor Proteins for Ras Signaling
An inability to activate Ras could be explained by an inability of phosphorylated EGFR to 
recruit core signaling adaptors such as SOS, Shc, and Grb2. We therefore investigated 
adaptor recruitment to EGF-stimulated and trapped dimer receptors using co-
immunoprecipitation. We treated SNAP-EGFR-expressing cells with EGF or (DNA-BG)2 to 
generate similar levels of phosphorylated receptor, immunoprecipitated the total EGFR, and 
then compared the quantity of adaptor proteins that coprecipitated after 5 min. Surprisingly, 
we did not observe a difference in the quantity of precipitated Grb2, SOS, and Shc between 
receptors stimulated with EGF or (DNA-BG)2, despite striking changes in the level of Ras-
GTP observed under the same conditions (Figures 3C–3F). These results show that 
differential recruitment of core adaptor proteins to EGFR cannot explain the differences in 
Ras signaling between our two conditions.
The Structure and Charge of the Crosslinker Do Not Significantly Impact EGFR 
Transphosphorylation or Signal Propagation
Given these surprising findings, we next investigated whether (DNA-BG)2 was contributing 
to the lack of Ras signaling in trapped EGFR dimers. Adding the reagents sequentially, with 
(DNA-BG)2 followed by EGF, resulted in Erk and Akt activation (Figure S2), suggesting 
that (DNA-BG)2 was not broadly inactivating EGFR. Next, we removed both charge and 
rigidity from the dimerizer by substituting the nucleic acid portion of (DNA-BG)2 with a 
highly flexible and uncharged polyethylene glycol (PEG) molecule. Treatment of SNAP-
EGFR-expressing cells with PEG26-BG2 triggered efficient formation of phosphorylated 
dimers but no Erk phosphorylation to levels above control (Figure S2). Similar results were 
observed for shorter PEG crosslinkers, including PEG9 and PEG5. Moreover, crosslinking a 
mutant EGFR (V924R), which is unable to form active asymmetric kinase dimers, did not 
result in receptor phosphorylation (Figure S2). These findings demonstrate that crosslinkers 
activate the receptor by promoting canonical interactions between the kinase domains but 
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that they are deficient in their ability to promote specific EGF-dependent active 
conformations necessary for Ras activation.
We also considered that the irreversible nature of BG-based crosslinker dimerization versus 
reversible EGF-induced dimerization could be a factor in the difference in downstream 
signaling. To address this, we made versions of the 20-bp (DNA-BG)2 with only 6, 8, or 10 
contiguous complementary bases to increase the off rate of the duplex. If the irreversibility 
of crosslinks was the explanation of the observed defect in signaling, we would expect an 
increase in Erk phosphorylation per unit of receptor phosphorylation as the duplex melting 
temperature approached 37°C. However, we did not observe an increase with any of the 
mismatched duplexes (Figure S2).
Phosphorylation of EGFR Dimers Is Not Sufficient for Nanoscale Oligomer Formation
Our findings demonstrate that, when EGFR dimers are trapped with linkers that do not 
significantly constrain receptor conformation, they can autophosphorylate and recruit key 
signaling adapters such as SOS but, surprisingly, do not stimulate Ras. We therefore sought 
to better understand how trapped receptor dimers might differ from EGF-induced complexes 
in events downstream of receptor phosphorylation, such as oligomerization and trafficking. 
We investigated this question by imaging cells treated with (DNA-BG)2 or EGF using 
stochastic optical reconstruction microscopy (STORM). We used an EGFR construct with a 
photoswitchable fluorescent protein (mEos 3.2) fused to the C terminus to resolve oligomers 
that might only be visible by imaging below the diffraction limit and expressed this 
construct at levels similar to those of receptors in previous experiments (Figure S1). We 
observed that, upon the addition of (DNA-BG)2 to SNAP-EGFR-mEos-expressing cells, the 
spatial arrangement of receptors was similar to that of unstimulated controls, whereas 
receptors stimulated with EGF led to rapid accumulation of bright foci after 10 min (Figures 
4A and S3). We quantified images of cells treated with media alone, EGF, or (DNA-BG)2 
and constructed pairwise distance histograms for each condition. A peak in the histogram 
indicates an increase in receptor local density compared to random at a given length scale. 
Compared to untreated cells, we found an increase in the histogram height (indicative of 
increased dimers and small oligomers) as well as width (indicative of the formation of larger 
oligomers) in cells treated with EGF. In contrast, the analysis of receptor distribution in the 
(DNA-BG)2-treated cells showed only a modest increase in histogram height, consistent 
with an increased dimer fraction, but no increase in histogram width, indicative of no change 
in the size of clusters when compared to untreated cells (Figure 4B).
To further investigate the degree of oligomerization, we performed single-molecule 
precipitation of SNAP-EGFR-EGFP receptors treated with biotinylated EGF or biotinylated 
(DNA-BG)2 after 5 min. We precipitated Triton X-100-disrupted cells onto neutravidin-
coated slides as previously described (Lee et al., 2013) to immobilize ligand-bound receptor 
complexes, and we imaged the intensity of individual fluorescent spots as a proxy for the 
number of EGFR molecules in each complex (Figure 4C). We observed an increased ratio of 
dimers to monomers in both conditions compared to controls but uniquely observed the 
formation of multiple brighter spots only when cells were treated with biotinylated-EGF 
(Figure 4D). Comparing the fluorescence intensity of these spots to those of the putative 
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monomer and dimer peaks suggested an average cluster size of approximately 7–15 
molecules for EGF-stimulated receptors (Figure 4E) after 5 min.
In addition to studying receptor arrangements at fixed time points, we also imaged the 
dynamic reorganization of EGFR on live cells. To do so, we used total internal reflection 
fluorescence (TIRF) microscopy to follow the EGFR trafficking in real time, using clathrin-
coated pits as a frame of reference. Although non-clathrin mediated endocytosis may 
contribute to EGFR dynamics under certain conditions, we found that a significant fraction 
of EGF-stimulated receptors were recruited to clathrin-coated pits at the EGF concentration 
used in our studies, whereas the localization of (DNA-BG)2-treated receptors was largely 
unchanged compared to controls over the course of 20 min (Figures 4F, 4G, and S4). 
Therefore, EGF triggers conformational changes in the EGFR that are necessary for the 
oligomerization of phosphorylated receptors and their reorganization on live-cell 
membranes.
Discussion
If EGFR oligomerization and other cell-surface dynamics are necessary for efficient MAPK 
signal transduction, how might they be coupled to Ras activity? EGFR oligomerization 
could stimulate Ras activity by concentrating Ras and SOS in common signaling complexes, 
thereby increasing their effective molarity relative to broadly distributed GAPs, and 
cooperatively stimulating the formation of Ras-GTP. Consistent with this model, Ras 
dimerization and nanoclustering have been shown to affect downstream Erk signaling (Nan 
et al., 2015; Tian et al., 2007; Zhou et al., 2014). Alternatively, EGF binding may cause 
changes in EGFR transmembrane conformation associated with clustering and the formation 
of lipid microdomains required for signaling. For example, EGFR clusters have been shown 
to colocalize with membrane regions enriched for PIP2(4,5) (Laketa et al., 2014), and the 
GEF activity of SOS can be modulated by charged lipids, including PIP2(4,5) (Gureasko et 
al., 2008; Zhao et al., 2007).
Independent of the detailed mechanism, our findings have important implications for 
understanding the regulation of Ras—and, possibly, other signaling molecules—by EGFR. 
We can conclude that conformational changes and/or other processes associated with EGF 
binding are necessary for oligomer formation and that these higher order EGFR oligomers 
may be more potent activators of Ras, on a molecule-to-molecule basis, when compared to 
phosphorylated dimers. Such EGF-dependent formation of EGFR nanoclusters may add an 
additional layer of spatial regulation to growth factor signaling, which aligns with an 
emerging view of how Ras regulates downstream pathways, through the formation of similar 
higher order species. Our findings also emphasize that not all EGFR dimers (or oligomers) 
are the same, and, depending on the initiating signal, receptor activation may evolve very 
differently. For example, a recent elegant dissection of structural and functional properties of 
EGFR dimers induced by different ligands suggests that more stable receptor dimers induce 
more transient profiles of receptor phosphorylation and downstream pathway activation, 
presumably by being long lived enough to recruit negative-feedback regulators (Freed et al., 
2017). Our findings argue that, in addition to the kinetics of receptor activation, the spatial 
distribution of receptors following their activation is a critical determinant of downstream 
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signal propagation. Long-lived trapped dimers are signaling deficient not because they fail to 
accumulate substantial phosphorylation and recruit adapters but, perhaps, because tertiary or 
quaternary interaction are structurally incompatible with subsequent organization into 
effective signaling platforms. Finally, our results demonstrate that receptor activation and 
signal transduction can be mechanistically decoupled. This finding has important 
implications for the development of future therapeutics, which could specifically target 
receptor organization rather than activation to modulate signal transduction through specific 
pathways.
Experimental Procedures
Details are provided in the Supplemental Information.
Cell Signaling Assays
Cells stably expressing SNAP-EGFR were grown to 70%–80% confluency and then serum 
starved for 6–8 hr prior to stimulus with EGF or (DNA-BG)2 at 37°C, lysed, and prepared 
for western blots. For quantitative western blotting, secondary antibodies conjugated to 
either Alexa Fluor 680 or DyLight 800 were used, and blots were imaged on a LI-COR 
Biosciences imaging system. Scans were quantified and analyzed by densitometry. 
Measurements were normalized to loading controls and shown as the mean and SD of 3 
independent experiments.
Storm
HEK293-SNAP-EGFR-mEos cells were serum starved for 6 hr and then incubated with the 
indicated stimuli at 37°C for 10 min. Cells were fixed and imaged with an inverted 
microscope using TIRF illumination, 1003 magnification, and a 561-nm laser at 60 Hz. 
Once every 10 frames, mEos was converted from green to red state with 405-nm 
illumination. Images from 10 cells per condition were corrected for blinking as previously 
described (Puchner et al., 2013), and the molecular positions were then used to calculate all 
the pairwise distances as previously described (van Lengerich et al., 2017).
Single-Molecule IP
HEK293-SNAP-EGFR-EGFP cells were treated with 8 nm of EGF-biotin or 2 μM of (BG-
DNA)2-biotin for 5 min at 37°C, and then lysed with 1% Triton X-100 buffer. Lysates were 
incubated on neutravidin-coated PEG slides and imaged by TIRF microscopy. Over 3 
independent experiments, monomer, dimer, and cluster populations were identified by 
bleaching steps and analysis of pixel intensity histograms.
Clathrin Colocalization
HEK293 cells were transfected with SNAP-EGFR-EGFP and clathrin light chain-dsRed 
using Lipofectamine 2000. Cells were imaged 48 hr later, live at 37°C with various stimuli. 
SNAP-EGFR-EGFP enrichment at clathrin structures was calculated as the difference 
between the average fluorescence inside and outside regions enriched for dsRed. Each 
condition represents 10 cells pooled across 7 independent experiments.
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Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Highlights
• Chemical-genetic approach to form stable phosphorylated EGFR dimers on 
cells
• Chemically induced dimers recruit adaptors to a similar extent as EGF-
activated EGFR
• SOS, Grb2, and Shc recruitment to EGFR dimers is not sufficient for Ras 
activation
• EGF induces conformational changes necessary for higher order oligomer 
formation
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Figure 1. Decoupling EGFR Dimerization and Transphosphorylation from Other EGFInduced 
Conformational and Spatial Changes
(A) EGFR exists in a tethered monomer or an inactive dimer formation. Upon EGF binding, 
it adopts an extended dimer conformation and undergoes auto-transphosphorylation. 
Phosphorylated dimers recruit adaptor proteins to EGFR, resulting in activation of the Ras-
MAPK pathway.
(B) EGF binding to EGFR also results in rapid changes in spatial organization from 
monomers (i) to dimers (ii); to higher order multimers and nanoscale clusters (iii-iv); to 
micron scale clusters in clathrin-coated pits (v); and, finally, to endosomes (vi).
(C) A chemical genetic system utilizing a SNAP-tag on the N terminus of full-length EGFR 
and BG-modified DNA dimers as crosslinkers.
(D) Representative western blot of lysates from cells treated with 8 nM EGF or 2 μM (DNA-
BG)2. To maintain DNA hybridization, SDS-PAGE samples were not boiled. EGFR dimers 
(d) and monomers (m) are indicated with arrows.
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Figure 2. Quantitative Comparison of Tyrosine Phosphorylation after Dimerization by EGF or 
(DNA-BG)2
(A) DNA-dimerized receptors can be revealed by PAGE without boiling or can be boiled to 
reveal a monomer for direct comparison to EGFR monomers. d, dimer; m, monomer; RT, 
room temperature.
(B) Representative western blot of boiled lysates from cells treated with serum-free media 
(nt, no treatment), 8 nM EGF or 2 μM (DNA-BG)2 at various tyrosines.
(C) Mean fold increase of total EGFR and phosphotyrosines upon EGF or (DNA-BG)2 
treatment compared to no treatment control (n = 3; error bars indicate SD).
Liang et al. Page 14
Cell Rep. Author manuscript; available in PMC 2018 April 25.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 3. Trapped EGFR Dimers Recruit Adaptors with Similar Stoichiometry to EGF-
Stimulated Cells but Do Not Activate Ras
(A) Representative western blot showing lysates from cells treated with either 8 nM EGF, 2 
μM (DNA-BG)2, or serum-free media (mock) for 5 min. The same lysates were used in a 
RasGTP pull-down, and samples were blotted for total Ras.
(B) Mean RasGTP levels in each treatment compared to negative control (n = 3; error bars 
indicate SD).
(C) Representative blot of Grb2 co-immunoprecipitation (coIP) with EGFR on lysates from 
treated cells.
(D) Representative blot of SOS coIP with EGFR.
(E) Representative blot of Shc coIP with EGFR.
(F) Quantification of adaptor coIP in treated cells compared to negative controls. Signals for 
each adaptor were normalized to total EGFR levels in the pull-down sample and plotted as 
mean fold increase over mock treatment (n = 3; error bars indicate SD).
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Figure 4. Trapped EGFR Dimers Do Not Form Nanoscale Spatial Intermediates or Traffic to 
Clathrin-Coated Pits
(A) Representative images of HEK293-SNAP-EGFR-mEos cells incubated with serum-free 
media (mock), 8 nM EGF or 2 μM (DNA-BG)2 for 10 min and then imaged by STORM. 
Scale bars, 10 μm.
(B) Pairwise correlation analysis of STORM images graphed as median and standard error 
(n = 10 cells per condition).
(C) Representative images of single-molecule IP of SNAP-EGFR-EGFP cells treated with 
biotin (bt)-EGF or bt-(DNA-BG)2 for 5 min. Ligand-bound receptors from lysates were 
immobilized on neutravidin-coated slides and imaged. EGFR monomers (m) appear as blue 
spots, dimers (d) appear as pink spots, and clusters (c) appear as larger yellow spots.
(D) Mean monomer, dimer, and cluster populations of EGFR graphed as a percentage of the 
sample (n = 3 independent experiments; error bars indicate SD).
(E) Representative EGF-biotin-treated sample with counts of relative intensity per molecule. 
The blue shaded region represents the monomer portion, the green shaded region represents 
the dimer portion, and zoom represents the cluster portion. The average number of EGFR 
molecules per cluster was estimated by dividing the average intensity of the clusters by the 
intensity of a monomer.
(F) TIRF images of HEK293 cells co-transfected with SNAP-EGFR-EGFP and clathrin-
light chain-dsRed after treatment with 8 nM EGF, 2 μM DNA, or serum-free media at 15 
min. Scale bar, 1 μm.
(G) Enrichment of SNAP-EGFR-EGFP at clathrin-coated pits over time after treatment with 
8 nM EGF, 2 μM (DNA-BG)2, or serum-free media graphed as mean and SD (n = 10 cells 
per condition).
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